Twist Biopharma Solutions

Where in vivo meets in vitro for end-to-end antibody discovery

Workflows and Corresponding Timelines

We offer three workflow options to our partners to ensure their needs are met within their desired timelines. Choose which workflow best fits your needs, or work with a scientist to determine a path.

Introducing 
Twist Gold Standard

In vivo, in vitro and in silico pathways simultaneously

Not sure which path is right for you? Don’t settle for just one! At Twist Biopharma Solutions, we recognized that discovery is not one-size-fits-all and there are inherent limitations to all technologies out there. Our flagship discovery workflow—the Twist Gold Standard in Antibody Discovery—lets our partners leverage more than one pathway. That mitigates risk and ensures more shots on goal.

Want to learn more about why our Gold Standard offering sets the standard for antibody discovery?

Our Numbers Speak for Themselves

400+

Successful mAb discovery campaigns completed in industry-leading timelines

200+

Partnerships spanning all therapeutic areas

4+

mAb candidates discovered by Twist Biopharma Solutions in clinical trials

3+

Industry’s best platforms spanning three different technologies to ensure all shots on goal

Companies We've Partnered With

What Scientists Have to Say

Twist is the only synthetic DNA provider who can deliver the quantity and quality of DNA we need for our projects rapidly. We are working with them not only as a vendor for synthetic genes and antibodies, but have expanded our relationship to leverage the Twist Biopharma capabilities, which we believe complement our antibody discovery efforts.”

ROBERT CARNAHAN, PHD
Associate Director of the Vanderbilt
Vaccine Center

Our platform rapidly generates and validates new targets for treating challenging cancers. Working with Abveris will enable us to quickly identify and select highly specific antibodies for those targets, so that we can take the best antibody forward to address the needs of particular patient populations.”

JEFF GOLDBERG, CEO
Associate Director of the Vanderbilt
 

Explore More

Twist’s Gold Standard in Antibody Discovery

Product SheetAntibodies

Download the product sheet

Library of Libraries

PosterBiopharma

Download the poster

Accelerate Your Discovery Efforts with Twist Antibody Libraries

Product SheetBiopharma

Download the product sheet

Writing the Future of Biologics to Discover and Optimize Antibodies

WebinarBiopharma

View the presentation

Get in Touch With Us

Antibody enthusiasts are standing by and would love to hear more about your discovery needs. Challenging targets welcome!